LNCaP: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[File:LNCaP.jpg|thumb]] [[File:Comparison of cancer cell lines.png|thumb]] [[File:Thalmann figure.png|thumb]] {{Short description|A human prostate cancer cell line used in research}}
{{Short description|Human prostate cancer cell line}}


'''LNCaP''' is a human [[prostate cancer]] cell line commonly used in [[cancer research]]. It was established from a metastatic lesion of human prostatic adenocarcinoma in the left supraclavicular lymph node of a 50-year-old Caucasian male. LNCaP cells are androgen-sensitive, meaning they require [[androgens]] for growth, which makes them a valuable model for studying [[androgen receptor]] signaling and prostate cancer progression.
== Overview ==
[[File:LNCaP.jpg|thumb|right|LNCaP cells under a microscope]]
'''LNCaP''' is a human [[prostate cancer]] cell line commonly used in [[cancer research]]. It was established from a metastatic lesion of human prostatic adenocarcinoma in the left supraclavicular lymph node of a 50-year-old Caucasian male. LNCaP cells are androgen-sensitive, meaning their growth is stimulated by [[androgens]], which are male hormones such as [[testosterone]].


==Characteristics==
== Characteristics ==
LNCaP cells exhibit several key characteristics that make them useful for research:
LNCaP cells exhibit several key characteristics that make them valuable for research:


* '''Androgen Sensitivity''': LNCaP cells express the [[androgen receptor]] (AR) and require androgens for optimal growth. This property is crucial for studying the role of androgens in prostate cancer.
* '''Androgen Sensitivity''': LNCaP cells require androgens for optimal growth, making them a model for studying androgen-dependent prostate cancer.
* '''PSA Production''': These cells produce [[prostate-specific antigen]] (PSA), a protein used as a marker in prostate cancer diagnosis and monitoring.
* '''Mutation Profile''': LNCaP cells have a mutation in the [[androgen receptor]] gene, which affects their response to androgens.


* '''PSA Production''': LNCaP cells produce [[prostate-specific antigen]] (PSA), a protein commonly used as a biomarker for prostate cancer diagnosis and monitoring.
== Applications in Research ==
[[File:Comparison_of_cancer_cell_lines.png|thumb|left|Comparison of various cancer cell lines, including LNCaP]]
LNCaP cells are widely used in prostate cancer research to:


* '''Genetic Profile''': LNCaP cells have a mutation in the AR gene, which affects their response to androgens and anti-androgens. This mutation is often studied to understand resistance mechanisms to [[androgen deprivation therapy]].
* Study the mechanisms of androgen receptor signaling and its role in prostate cancer progression.
* Investigate the effects of anti-androgen drugs and other therapeutic agents.
* Explore the molecular pathways involved in prostate cancer metastasis and resistance to therapy.


* '''Growth Characteristics''': LNCaP cells grow as adherent monolayers and have a doubling time of approximately 60 hours under standard culture conditions.
== Comparison with Other Cell Lines ==
LNCaP cells are often compared with other prostate cancer cell lines such as [[PC-3]] and [[DU145]]. Unlike LNCaP, PC-3 and DU145 are androgen-independent, meaning they do not require androgens for growth. This difference makes LNCaP particularly useful for studying the transition from androgen-dependent to androgen-independent prostate cancer.


==Applications in Research==
== Limitations ==
LNCaP cells are widely used in various areas of prostate cancer research:
While LNCaP cells are a valuable tool in prostate cancer research, they have limitations:
 
* '''Drug Testing''': Researchers use LNCaP cells to test the efficacy of new drugs and therapies targeting the androgen receptor pathway.
 
* '''Mechanistic Studies''': The cell line is used to study the molecular mechanisms of prostate cancer progression, including the role of androgens and the AR.
 
* '''Biomarker Discovery''': LNCaP cells help in identifying potential biomarkers for prostate cancer diagnosis and prognosis.
 
* '''Resistance Mechanisms''': The cell line is used to investigate mechanisms of resistance to androgen deprivation therapy and other treatments.
 
==Limitations==
While LNCaP cells are a valuable tool, they have limitations:


* '''Genetic Drift''': Over time, LNCaP cells can undergo genetic changes that may affect experimental outcomes.
* '''Genetic Drift''': Over time, LNCaP cells can undergo genetic changes that may affect experimental outcomes.
* '''Limited Metastatic Potential''': LNCaP cells have a lower metastatic potential compared to other cell lines, which may limit their use in studying advanced prostate cancer.


* '''Limited Heterogeneity''': As a single cell line, LNCaP does not capture the genetic and phenotypic diversity of prostate cancer in patients.
== Related pages ==
 
* '''Androgen Dependence''': The androgen-sensitive nature of LNCaP cells may not fully represent castration-resistant prostate cancer.
 
==Also see==
* [[Prostate cancer]]
* [[Prostate cancer]]
* [[Androgen receptor]]
* [[Androgen receptor]]
* [[Prostate-specific antigen]]
* [[Prostate-specific antigen]]
* [[PC-3]]
* [[DU145]]
== See also ==
* [[Cancer cell line]]
* [[Androgen deprivation therapy]]
* [[Androgen deprivation therapy]]
* [[Cancer cell line]]
* [[Hormone therapy (oncology)]]
 
{{Prostate cancer}}
{{Cell lines}}


[[Category:Prostate cancer]]
[[Category:Prostate cancer]]
[[Category:Cell lines]]
[[Category:Cell lines used in cancer research]]
[[Category:Cancer research]]

Latest revision as of 20:30, 21 February 2025

Human prostate cancer cell line


Overview[edit]

LNCaP cells under a microscope

LNCaP is a human prostate cancer cell line commonly used in cancer research. It was established from a metastatic lesion of human prostatic adenocarcinoma in the left supraclavicular lymph node of a 50-year-old Caucasian male. LNCaP cells are androgen-sensitive, meaning their growth is stimulated by androgens, which are male hormones such as testosterone.

Characteristics[edit]

LNCaP cells exhibit several key characteristics that make them valuable for research:

  • Androgen Sensitivity: LNCaP cells require androgens for optimal growth, making them a model for studying androgen-dependent prostate cancer.
  • PSA Production: These cells produce prostate-specific antigen (PSA), a protein used as a marker in prostate cancer diagnosis and monitoring.
  • Mutation Profile: LNCaP cells have a mutation in the androgen receptor gene, which affects their response to androgens.

Applications in Research[edit]

Comparison of various cancer cell lines, including LNCaP

LNCaP cells are widely used in prostate cancer research to:

  • Study the mechanisms of androgen receptor signaling and its role in prostate cancer progression.
  • Investigate the effects of anti-androgen drugs and other therapeutic agents.
  • Explore the molecular pathways involved in prostate cancer metastasis and resistance to therapy.

Comparison with Other Cell Lines[edit]

LNCaP cells are often compared with other prostate cancer cell lines such as PC-3 and DU145. Unlike LNCaP, PC-3 and DU145 are androgen-independent, meaning they do not require androgens for growth. This difference makes LNCaP particularly useful for studying the transition from androgen-dependent to androgen-independent prostate cancer.

Limitations[edit]

While LNCaP cells are a valuable tool in prostate cancer research, they have limitations:

  • Genetic Drift: Over time, LNCaP cells can undergo genetic changes that may affect experimental outcomes.
  • Limited Metastatic Potential: LNCaP cells have a lower metastatic potential compared to other cell lines, which may limit their use in studying advanced prostate cancer.

Related pages[edit]

See also[edit]